(Q40328234)

19 September 2017

title

Peroxisome proliferator-activated receptor (PPAR)gamma is highly expressed in normal human pituitary gland (English)

1 reference

19 September 2017

Bogazzi F

1

1 reference

19 September 2017

Russo D

2

1 reference

19 September 2017

Locci MT

3

1 reference

19 September 2017

Chifenti B

4

1 reference

19 September 2017

Ultimieri F

5

1 reference

19 September 2017

Raggi F

6

1 reference

19 September 2017

Viacava P

7

1 reference

19 September 2017

Cecchetti D

8

1 reference

19 September 2017

Cosci C

9

1 reference

19 September 2017

Sardella C

10

1 reference

19 September 2017

Acerbi G

11

1 reference

19 September 2017

Gasperi M

12

1 reference

19 September 2017

Martino E

13

1 reference

19 September 2017

publication date

1 November 2005

1 reference

Journal of Endocrinological Investigation

19 September 2017

published in

1 reference

19 September 2017

volume

28

1 reference

19 September 2017

issue

10

1 reference

19 September 2017

page(s)

899-904

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03345321

19 September 2017

exact match

0 references

cites work

Peroxisome proliferator-activated receptor γ in diabetes and metabolism

1 reference

https://api.crossref.org/works/10.1007%2FBF03345321

PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345321

Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345321

Prospects for prevention and treatment of cancer with selective PPARgamma modulators (SPARMs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345321

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345321

PPARs and the complex journey to obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345321

Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345321

Be fit or be sick: peroxisome proliferator-activated receptors are down the road

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345321

Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345321

PPAR-gamma receptor ligands: novel therapy for pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345321

PPARgamma inhibits GH synthesis and secretion and increases apoptosis of pituitary GH-secreting adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345321

Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345321

Nitration of PPARgamma inhibits ligand-dependent translocation into the nucleus in a macrophage-like cell line, RAW 264

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345321

Peroxisome proliferator-activated receptors: nuclear control of metabolism

21 January 2018

1 reference

12 December 2020

Peroxisome proliferator-activated receptor gamma in diabetes and metabolism

1 reference

12 December 2020

Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.

1 reference

12 December 2020

Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation

1 reference

12 December 2020

Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells

1 reference

12 December 2020

Baseline and CRH-stimulated ACTH and cortisol levels after administration of the peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone, in Cushing's disease

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03345321

1 reference

Dimensions Publication ID

19 September 2017

1048796116

0 references

1 reference